Real-time context
Material company disclosures filed with the SEC.
Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Hepion Pharmaceuticals,…
Read moreCompass Diversified Holdings (NYSE:CODI) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Compass Diversified…
Read moreADIAL PHARMACEUTICALS, INC. (NASDAQ:ADIL) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. ADIAL PHARMACEUTICALS,…
Read moreInnventure, Inc. (NASDAQ:INV) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Innventure, Inc.'s stock currently…
Read moreOxford Square Capital Corp. (NASDAQ:OXSQ) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Oxford Square Capital…
Read moreEmergent BioSolutions Inc. (NYSE:EBS) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Emergent BioSolutions Inc.'s…
Read moreAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Healthcare company reported…
Read moreSHF Holdings, Inc. (NASDAQ:SHFS) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. SHF Holdings, Inc.'s stock currently…
Read morePassage BIO, Inc. (NASDAQ:PASG) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Healthcare company reported annual revenue…
Read moreAtara Biotherapeutics, Inc. (NASDAQ:ATRA) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Atara Biotherapeutics,…
Read moreScholar Rock Holding Corp (NASDAQ:SRRK) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Healthcare company reported annual…
Read moreTheravance Biopharma, Inc. (NASDAQ:TBPH) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. Theravance Biopharma, Inc.'s…
Read moreOFS Capital Corp (NASDAQ:OFS) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Financial Services company reported annual…
Read morePEDEVCO CORP (AMEX:PED) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. PEDEVCO CORP's stock currently trades at $0.70…
Read morePrime Medicine, Inc. (NASDAQ:PRME) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Healthcare company reported annual…
Read moreWEST BANCORPORATION INC (NASDAQ:WTBA) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on March 03, 2026. The Financial Services company's…
Read moreSRx Health Solutions, Inc. (NYSE:SRXH) filed a Form 8-K with the Securities and Exchange Commission on March 03, 2026, disclosing a material event. SRx Health Solutions, Inc.'s…
Read moreHNI CORP (NYSE:HNI) filed its annual report (Form 10-K) with the Securities and Exchange Commission on March 03, 2026. The Industrials company reported annual revenue of and net…
Read moreBloomin' Brands, Inc. (NASDAQ:BLMN) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on March 03, 2026. The Consumer Cyclical company's…
Read moreTHOR INDUSTRIES INC (NYSE:THO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on March 03, 2026. The Consumer Cyclical company reported Q0…
Read more
